SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are facing downward pressure as investors scrutinize the company's aggressive capital expenditure on AI infrastructure, which has significantly weighed on free cash flow despite solid revenue growth. The community remains deeply divided, with some investors viewing the dip as a long-term accumulation opportunity in a dominant ad business, while vocal critics are expressing frustration over the heavy spending and questioning the execution of Meta's AI strategy.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors brace for high-stakes earnings, with the community laser-focused on how AWS growth and AI infrastructure spending will influence the stock's valuation. While some traders are bracing for volatility due to concerns over high capital expenditures, others are aggressively buying the dip, viewing Amazon as a long-term beneficiary of the structural shift toward AI.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad approval of Anktiva for bladder and lung cancer treatments, a move that bolsters global expansion sentiment. While retail investors remain focused on potential upcoming earnings and the prospect of a short squeeze due to high short interest, they are actively debating the timing of further announcements and the company's long-term commercial strategy.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending following an exceptionally strong half-year earnings report that featured double-digit revenue and profit growth, prompting the company to raise its full-year guidance across the board. The community is buzzing over the company's successful turnaround, robust cash flow, and significant long-term potential in the Small Modular Reactor (SMR) and defense sectors, with many investors viewing current momentum as a setup for sustained future growth.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors weigh strong earnings and a massive hyperscaler backlog against broader macro headwinds and sector-wide volatility. While some market participants are aggressively buying the dip, citing reliable historical price recovery patterns, others are concerned about financing constraints and persistent macroeconomic uncertainty impacting high-growth infrastructure plays.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending following a massive sell-off triggered by the abrupt departure of top executives, a delayed financial filing, and news of an SEC investigation into its accounting practices. While the community is debating whether the stock is a severely oversold deep-value opportunity or a sign of deeper systemic risk, many are actively monitoring for a technical rebound driven by the company's strong institutional backing and cash flow profile.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending following an earnings report that highlighted strong Azure cloud growth and positive management commentary on AI monetization, which has successfully eased investor concerns regarding capital expenditure. Community sentiment has shifted sharply toward optimism, with many traders discussing a potential short squeeze and a rotation back into high-quality software names.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is trending as investors react to the company's aggressive share buyback program and ongoing Ethereum accumulation strategy, which management is using to address the discount between share price and asset value. The community remains heavily divided, with some traders optimistic about a potential rally fueled by the Clarity Act and institutional inflows, while frustrated long-term shareholders continue to express deep skepticism regarding management and the stock's volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is facing significant selling pressure and heightened volatility as traders react to a mixed FDA advisory panel outcome regarding peptide compounds and a new lawsuit filed by the FTC. While long-term investors are expressing confidence by adding to their positions and pointing to high institutional ownership, the community remains divided between those viewing the recent pullback as a temporary buying opportunity and those concerned by regulatory overhang and potential impacts on the business model.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending amid significant volatility as investors react to the company's resubmission of its BLA for RP1 and anticipation surrounding an upcoming FDA advisory committee meeting. Community sentiment is deeply polarized, with intense debate over the reliability of the clinical data, the potential for political influence on regulatory outcomes, and fears that the stock may be subject to a pump-and-dump scheme prior to a third expected rejection.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates

Corcept (CORT) delivered earnings and revenue surprises of +1,000.00% and +18.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today reported its results for the...

Are Medical Stocks Lagging  Corcept Therapeutics (CORT) This Year?

Here is how Corcept Therapeutics (CORT) and Quest Diagnostics (DGX) have performed compared to their sector so far this year.

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).Conference Call...

Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm

Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm PR Newswire NEW YORK, June 25, 2026 NEW YORK, June 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...

Corcept Resubmits NDA for Relacorilant in Cushing's Syndrome

CORT resubmits relacorilant NDA for Cushing's syndrome, with updated analyses and data from multiple clinical studies supporting the filing.

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushings Syndrome

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced it has resubmitted...

CORT Stock Rises 42% in a Month: Here's What You Should Know

Corcept shares surge 42% in a month as relacorilant advances in Cushing's syndrome and Lifyorli approval to expand the company's revenue base.

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the presentation of...

Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

$CORT Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.40 up 21.21% YoY
• Reported revenue of $256.15M up 31.74% YoY

Stocktwits

Corcept Therapeutics Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.40 up 21.21% YoY
• Reported revenue of $256.15M up 31.74% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

CORT Stock Hits Highest Levels In 2026 – Cushing’s Syndrome Drug NDA Resubmission Extends 5-Session Rally

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$92.95
Prev Close	$94.19
Open	$94.84
Dividend Yield	0.00%
50-Day Moving Average	$81.35
Beta	1.35
Avg. Volume	1.01M
PE Ratio	265.57

52-Week High	$97.63
52-Week Low	$28.66
Market Capitalization	$10.11B
EPS (Annual)	$0.8182
Price to Book	15.64
Revenue Per Employee	$1.04M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CORTCorcept Therapeutics Inc

Latest CORT News